Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and gyki 52466

3,5-dihydroxyphenylglycine has been researched along with gyki 52466 in 1 studies

Compound Research Comparison

Studies
(3,5-dihydroxyphenylglycine)
Trials
(3,5-dihydroxyphenylglycine)
Recent Studies (post-2010)
(3,5-dihydroxyphenylglycine)
Studies
(gyki 52466)
Trials
(gyki 52466)
Recent Studies (post-2010) (gyki 52466)
301161312038

Protein Interaction Comparison

ProteinTaxonomy3,5-dihydroxyphenylglycine (IC50)gyki 52466 (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)10
Glutamate receptor 2Rattus norvegicus (Norway rat)10
Glutamate receptor 3Rattus norvegicus (Norway rat)10
Glutamate receptor 4Rattus norvegicus (Norway rat)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelland, EE; Toms, NJ1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and gyki 52466

ArticleYear
Group I metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death.
    European journal of pharmacology, 2001, Jul-27, Volume: 424, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Benzoates; Benzodiazepines; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Kainic Acid; Oligodendroglia; Rats; Receptors, AMPA; Receptors, Metabotropic Glutamate; Resorcinols; Stem Cells

2001